432 related articles for article (PubMed ID: 22744010)
21. [The anti-tumor effects of dendritic cells co-cultured with cytokine induced killer cells after chemotherapy].
Zhang S; Zhang SQ; Bai CX
Zhonghua Jie He He Hu Xi Za Zhi; 2004 May; 27(5):315-9. PubMed ID: 15196340
[TBL] [Abstract][Full Text] [Related]
22. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
Lin T; Song C; Chuo DY; Zhang H; Zhao J
Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
[TBL] [Abstract][Full Text] [Related]
23. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.
Jiang J; Xu N; Wu C; Deng H; Lu M; Li M; Xu B; Wu J; Wang R; Xu J; Nilsson-Ehle P
Anticancer Res; 2006; 26(3B):2237-42. PubMed ID: 16821594
[TBL] [Abstract][Full Text] [Related]
24. Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis.
Wang ZX; Cao JX; Wang M; Li D; Cui YX; Zhang XY; Liu JL; Li JL
Cytotherapy; 2014 Jul; 16(7):934-45. PubMed ID: 24794183
[TBL] [Abstract][Full Text] [Related]
25. [Clinical efficacy of immunotherapy of dendritic cell and cytokine-induced killer cell combined with chemotherapy for treatment of multiple myeloma].
Zhong GC; Yan B; Sun Y; Zhang XY; Chen J; Su Y; Sun HP; Zhu B
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1000-3. PubMed ID: 23363790
[TBL] [Abstract][Full Text] [Related]
26. Effect of maintenance therapy with dendritic cells: cytokine-induced killer cells in patients with advanced non-small cell lung cancer.
Shi SB; Ma TH; Li CH; Tang XY
Tumori; 2012; 98(3):314-9. PubMed ID: 22825506
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
28. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
[TBL] [Abstract][Full Text] [Related]
29. Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma.
Zhao X; Zhang Z; Li H; Huang J; Yang S; Xie T; Huang L; Yue D; Xu L; Wang L; Zhang W; Zhang Y
Cancer Lett; 2015 Jul; 362(2):192-8. PubMed ID: 25843292
[TBL] [Abstract][Full Text] [Related]
30. Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice.
Shi S; Tao L; Song H; Chen L; Huang G
APMIS; 2014 May; 122(5):380-91. PubMed ID: 24628659
[TBL] [Abstract][Full Text] [Related]
31. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
[TBL] [Abstract][Full Text] [Related]
32. A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients.
Zhong R; Han B; Zhong H
Tumour Biol; 2014 Feb; 35(2):987-94. PubMed ID: 24006222
[TBL] [Abstract][Full Text] [Related]
33. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the Clinical Efficacy of Dendritic Cell -cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer.
Xu H; Qin W; Feng H; Song D; Yang X; Zhang J
Immunol Invest; 2021 Aug; 50(6):622-633. PubMed ID: 32718264
[No Abstract] [Full Text] [Related]
35. Prospective phase II study of post-surgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients.
Kimura H; Iizasa T; Ishikawa A; Shingyouji M; Yoshino M; Kimura M; Inada Y; Matsubayashi K
Anticancer Res; 2008; 28(2B):1229-38. PubMed ID: 18505060
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
[TBL] [Abstract][Full Text] [Related]
37. Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.
Jiang N; Qiao G; Wang X; Morse MA; Gwin WR; Zhou L; Song Y; Zhao Y; Chen F; Zhou X; Huang L; Hobeika A; Yi X; Xia X; Guan Y; Song J; Ren J; Lyerly HK
Clin Cancer Res; 2017 Sep; 23(17):5066-5073. PubMed ID: 28611200
[No Abstract] [Full Text] [Related]
38. Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non-small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials.
Xiao Z; Wang CQ; Feng JH; Zhou MH; Wang YZ; Li NN; Sun YP; Liu SY; Yao XS; Li CW; Ma B; Ding J; Chen L
Cytotherapy; 2019 Feb; 21(2):125-147. PubMed ID: 30554868
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer.
Zhu Y; Zhang H; Li Y; Bai J; Liu L; Liu Y; Qu Y; Qu X
Cancer Immunol Immunother; 2013 Oct; 62(10):1629-35. PubMed ID: 23974720
[TBL] [Abstract][Full Text] [Related]
40. Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer.
Mao Q; Li L; Zhang C; Sun Y; Liu S; Cui S
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1055-8. PubMed ID: 26051718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
